Ha Tay Pharmaceutical JSC (HNX:DHT)

Market Cap	7.28T
Revenue (ttm)	2.16T
Net Income (ttm)	72.94B
Shares Out	90.57M
EPS (ttm)	805.26
PE Ratio	99.84
Forward PE	n/a
Dividend	909.09 (1.13%)
Ex-Dividend Date	Oct 30, 2024

Volume	21,610
Average Volume	16,097
Open	81,500
Previous Close	79,909
Day's Range	79,900 - 86,800
52-Week Range	62,273 - 100,818
Beta	0.19
RSI	66.70
Earnings Date	Oct 31, 2025

About Ha Tay Pharmaceutical JSC

Ha Tay Pharmaceutical JSC manufactures, trades in, imports, and exports medicines, chemical raw materials for medicine, medicinal materials, and medical equipment. In addition, the company provides medicinal products manufacturing services; and import-export authorization services, as well as supplies pharmaceutical ingredients for enterprises. The company was founded in 1965 and is based in Hanoi, Vietnam.

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DHT

Financial Performance

In 2024, Ha Tay Pharmaceutical JSC's revenue was 2.09 trillion, an increase of 4.35% compared to the previous year's 2.00 trillion. Earnings were 71.77 billion, a decrease of -15.62%.